These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10606085)

  • 1. Pharmacokinetics of (-)-beta-D-dioxolane guanine and prodrug (-)-beta-D-2,6-diaminopurine dioxolane in rats and monkeys.
    Chen H; Schinazi RF; Rajagopalan P; Gao Z; Chu CK; McClure HM; Boudinot FD
    AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1625-30. PubMed ID: 10606085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatographic determination of (-)-beta-D-2,6-diaminopurine dioxolane and its metabolite, dioxolane guanosine, using ultraviolet and on-line radiochemical detection.
    Rajagopalan P; Gao Z; Chu CK; Schinazi RF; McClure HM; Boudinot FD
    J Chromatogr B Biomed Appl; 1995 Oct; 672(1):119-24. PubMed ID: 8590923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of 1-beta-D-2,6-diaminopurine dioxolane, a prodrug of the human immunodeficiency virus type 1 inhibitor 1-beta-D-dioxolane guanosine.
    Furman PA; Jeffrey J; Kiefer LL; Feng JY; Anderson KS; Borroto-Esoda K; Hill E; Copeland WC; Chu CK; Sommadossi JP; Liberman I; Schinazi RF; Painter GR
    Antimicrob Agents Chemother; 2001 Jan; 45(1):158-65. PubMed ID: 11120959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and anti-HIV activity of (-)-beta-D-(2R,4R)-1,3-dioxolane-2,6-diamino purine (DAPD) (amdoxovir) and (-)-beta-D-(2R,4R)-1,3-dioxolane guanosine (DXG) prodrugs.
    Narayanasamy J; Pullagurla MR; Sharon A; Wang J; Schinazi RF; Chu CK
    Antiviral Res; 2007 Sep; 75(3):198-209. PubMed ID: 17532483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotransformation and pharmacokinetics of prodrug 9-(beta-D-1,3-dioxolan-4-yl)-2-aminopurine and its antiviral metabolite 9-(beta-D-1,3-dioxolan-4-yl)guanine in mice.
    Manouilov KK; Manouilova LS; Boudinot FD; Schinazi RF; Chu CK
    Antiviral Res; 1997 Aug; 35(3):187-93. PubMed ID: 9298758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of (-)-beta-D-2-aminopurine dioxolane and (-)-beta-D-2-amino-6-chloropurine dioxolane and their antiviral metabolite (-)-beta-D-dioxolane guanine in rhesus monkeys.
    Chen H; Boudinot FD; Chu CK; Mcclure HM; Schinazi RF
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2332-6. PubMed ID: 8891140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dioxolane guanosine, the active form of the prodrug diaminopurine dioxolane, is a potent inhibitor of drug-resistant HIV-1 isolates from patients for whom standard nucleoside therapy fails.
    Mewshaw JP; Myrick FT; Wakefield DA; Hooper BJ; Harris JL; McCreedy B; Borroto-Esoda K
    J Acquir Immune Defic Syndr; 2002 Jan; 29(1):11-20. PubMed ID: 11782585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1.
    Borroto-Esoda K; Myrick F; Feng J; Jeffrey J; Furman P
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4387-94. PubMed ID: 15504868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S; Asif G; Narayanasamy J; Butler SD; George AL; Hurwitz SJ; Schinazi RF; Chu CK; Cote PJ; Gerin JL; Tennant BC
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3177-84. PubMed ID: 17606676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action and in vitro activity of 1',3'-dioxolanylpurine nucleoside analogues against sensitive and drug-resistant human immunodeficiency virus type 1 variants.
    Gu Z; Wainberg MA; Nguyen-Ba N; L'Heureux L; de Muys JM; Bowlin TL; Rando RF
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2376-82. PubMed ID: 10508010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance liquid chromatographic determination of (-)-beta-D-2-aminopurine dioxolane and (-)-beta-D-2-amino-6-chloropurine dioxolane, and their metabolite (-)-beta-D-dioxolane guanine in monkey serum, urine and cerebrospinal fluid.
    Chen H; Manouilov KK; Chu CK; Schinazi RF; McClure HM; Boudinot FD
    J Chromatogr B Biomed Sci Appl; 1997 Apr; 691(2):425-32. PubMed ID: 9174280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anabolism of amdoxovir: phosphorylation of dioxolane guanosine and its 5'-phosphates by mammalian phosphotransferases.
    Feng JY; Parker WB; Krajewski ML; Deville-Bonne D; Veron M; Krishnan P; Cheng YC; Borroto-Esoda K
    Biochem Pharmacol; 2004 Nov; 68(9):1879-88. PubMed ID: 15450953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-HIV-1 activities of 1,3-dioxolane guanine and 2,6-diaminopurine dioxolane.
    Gu Z; Wainberg MA; Nguyen-Ba P; L'Heureux L; de Muys JM; Rando RF
    Nucleosides Nucleotides; 1999; 18(4-5):891-2. PubMed ID: 10432704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic assay for measurement of intracellular DXG triphosphate concentrations in peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected patients.
    Kewn S; Wang LH; Hoggard PG; Rousseau F; Hart R; MacNeela JP; Khoo SH; Back DJ
    Antimicrob Agents Chemother; 2003 Jan; 47(1):255-61. PubMed ID: 12499199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism of DApd/DXG against zidovudine- and lamivudine- drug resistant mutants: a molecular modelling approach.
    Chong Y; Borroto-Esoda K; Furman PA; Schinazi RF; Chu CK
    Antivir Chem Chemother; 2002 Mar; 13(2):115-28. PubMed ID: 12238529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DAPD (Emory University/Triangle Pharmaceuticals/Abbott Laboratories).
    Corbett AH; Rublein JC
    Curr Opin Investig Drugs; 2001 Mar; 2(3):348-53. PubMed ID: 11575703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and metabolism of 3'-azido-2',3'-dideoxy-5-methylcytidine in rhesus monkeys.
    Boudinot FD; Schinazi RF; Doshi KJ; McClure HM; Chu CK
    Drug Metab Dispos; 1993; 21(5):855-60. PubMed ID: 7902248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic evaluation of 3'-azido-2', 3'-dideoxyuridine-5'-O-valinate-hydrochloride as a prodrug of the anti-HIV nucleoside 3'-azido-2', 3'-dideoxyuridine.
    Kong L; Cooperwood JS; Huang SH; Chu CK; Boudinot FD
    Antivir Chem Chemother; 2003 Sep; 14(5):263-70. PubMed ID: 14694989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and metabolism of [14C]viramidine in rats and cynomolgus monkeys.
    Lin CC; Luu K; Lourenco D; Yeh LT
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2458-63. PubMed ID: 12878505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of the antiviral agent beta-L-3'-fluoro-2',3'-didehydro-2',3'-dideoxycytidine in rhesus monkeys.
    Asif G; Hurwitz SJ; Gumina G; Chu CK; McClure HM; Schinazi RF
    Antimicrob Agents Chemother; 2005 Feb; 49(2):560-4. PubMed ID: 15673733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.